Printer Friendly

MEDICAL DEVICES, INC. ANNOUNCES FDA 510(K) APPROVAL

 ST. PAUL, Minn., Nov. 18 ~PRNewswire~ -- Medical Devices, Inc. (NASDAQ: MDEV) (MDI), today announced that it has received FDA approval of its 510(K) application to market the company's Interferential Stimulator, the IF II(TM), for edema reduction. The IF II already has approval to be marketed for pain control applications.
 This approval now positions the IF II into a significantly larger market. According to Robert Wingrove, Sr., chairman, "Edema (swelling) is a major problem after surgery and trauma. We can now market the IF II as a product that not only reduces pain effectively but also helps reduce edema. The new applications for the IF II represent significant sales opportunities for Medical Devices, Inc."
 Shipments of the IF II for edema reduction in addition to pain control will begin immediately.
 Medical Devices, Inc. is a leading designer and manufacturer of electromedical rehabilitation and pain management products. The company's common stock is traded on the national over-the-counter market under the NASDAQ symbol "MDEV."
 -0- 11~18~92
 ~CONTACT: David B. Kaysen, president and CEO, or Jeffrey P. Shields, vice president of Finance, 612-631-0590, both of Medical Devices~
 (MDEV)


CO: Medical Devices, Inc. ST: Minnesota IN: MTC SU:

AL -- MN013 -- 2560 11~18~92 17:03 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 18, 1992
Words:206
Previous Article:BERGEN BRUNSWIG COMPLETES ACQUISITION OF DR. T.C. SMITH CO.
Next Article:EG&G CONTRACT AT KENNEDY SPACE CENTER NOT RENEWED
Topics:


Related Articles
Approval processes different for devices and drugs.
DANNINGER MEDICAL TECHNOLOGY, INC. ANNOUNCES FDA MARKETING CLEARANCE FOR SPINAL SYSTEM AND FORMATION OF ADVISORY BOARD
U.S. DRUG TESTING RECEIVES FDA MARKETING APPROVAL
U.S. DRUG TESTING INC. RECEIVES FDA MARKETING APPROVAL ON FLOW IMMUNOASSAY SYSTEM, MODEL 9000
U.S. ALCOHOL TESTING OF AMERICA RECEIVES FDA MARKETING APPROVAL FOR RECENTLY SUBMITTED OPIATE ASSAY
DANNINGER MEDICAL TECHNOLOGY, INC. ANNOUNCES FDA MARKETING CLEARANCE FOR SHOULDER THERAPY DEVICE
MEDICAL DEVICES, INC. ANNOUNCES FDA 510(k) APPROVAL FOR NEW PRODUCT
DANNINGER MEDICAL TECHNOLOGY, INC. SUBSIDIARY RECEIVES FDA MARKET CLEARANCE FOR ANTERIOR PORTION OF SYNERGY SYSTEM
Possis Medical, Inc. Receives FDA Response to AngioJet Thrombectomy System Submission
Possis Medical, Inc. Receives FDA Approval to Market Perma-Seal Dialysis Graft in U.S.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters